<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Medical Xpress news tagged with:achondroplasia</title>
            <link>https://medicalxpress.com/</link>
            <language>en-us</language> 
            <description>Medical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

                            <item>
                    <title>Clinical trial finds daily tablet increases growth in children with achondroplasia</title>
                    <description>A promising daily tablet is effective at increasing height and improving proportional limb growth in children with achondroplasia, the most common form of dwarfism, according to a new study. And the findings could spare these children from needing to have a daily injection to boost growth.</description>
                    <link>https://medicalxpress.com/news/2024-11-clinical-trial-daily-tablet-growth.html</link>
                    <category></category>
                    <pubDate>Mon, 18 Nov 2024 06:26:12 EST</pubDate>
                    <guid isPermaLink="false">news651133566</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/height-chart.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Bone growth drug may reduce sudden infant death syndrome in children with common form of dwarfism</title>
                    <description>A drug that boosts bone growth in children with the most common form of dwarfism may also reduce their chances of sudden infant death syndrome, sleep apnea, and needing surgery, according to a new study.</description>
                    <link>https://medicalxpress.com/news/2023-11-bone-growth-drug-sudden-infant.html</link>
                    <category></category>
                    <pubDate>Tue, 21 Nov 2023 14:25:20 EST</pubDate>
                    <guid isPermaLink="false">news619799113</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/knee-bone.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>US approves drug to improve growth in children with dwarfism</title>
                    <description>The US Food and Drug Administration on Friday approved for the first time a drug to improve growth in children with the most common type of dwarfism.</description>
                    <link>https://medicalxpress.com/news/2021-11-drug-growth-children-dwarfism.html</link>
                    <category></category>
                    <pubDate>Fri, 19 Nov 2021 13:32:22 EST</pubDate>
                    <guid isPermaLink="false">news556551139</guid>
                                    </item>
                            <item>
                    <title>Charting 60 years of treatments, health characteristics among people with dwarfism to improve quality of life</title>
                    <description>In a retrospective study believed to be one of the largest of its kind, researchers say they have successfully charted the health risks, growth patterns, and medical and surgical outcomes of 1,374 people with the most common form of dwarfism, called achondroplasia, seen over a 60-year period at four academic medical centers, including Johns Hopkins Medicine. The findings, according to the researchers, not only affirm some long-standing views and trends in the care of those with the condition, but also offer a standardized baseline, a blueprint investigators hope will serve to speed diagnosis and improve patients&#039; quality of life and health.</description>
                    <link>https://medicalxpress.com/news/2021-06-years-treatments-health-characteristics-people.html</link>
                    <category></category>
                    <pubDate>Mon, 21 Jun 2021 10:11:29 EDT</pubDate>
                    <guid isPermaLink="false">news543489085</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/charting-60-years-of-t.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>First targeted therapy for children with achondroplasia shows persistent height gain</title>
                    <description>Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily vosoritide treatment, a new study analysis finds. Results of the industry-sponsored study will be presented at ENDO 2021, the Endocrine Society&#039;s annual meeting.</description>
                    <link>https://medicalxpress.com/news/2021-03-therapy-children-achondroplasia-persistent-height.html</link>
                    <category></category>
                    <pubDate>Sat, 20 Mar 2021 15:41:22 EDT</pubDate>
                    <guid isPermaLink="false">news535473680</guid>
                                    </item>
                            <item>
                    <title>New drug shown to improve bone growth in children with achondroplasia in global phase III trial</title>
                    <description>A phase three global clinical trial led by the Murdoch Children&#039;s Research Institute (MCRI) has shown a new drug boosts bone growth in children born with achondroplasia, the most common type of dwarfism.</description>
                    <link>https://medicalxpress.com/news/2020-09-drug-shown-bone-growth-children.html</link>
                    <category></category>
                    <pubDate>Mon, 07 Sep 2020 08:28:34 EDT</pubDate>
                    <guid isPermaLink="false">news518686110</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2020/newdrugshown.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Drug boosts growth in youngsters with most common form of dwarfism, new study finds</title>
                    <description>A groundbreaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia—the most common type of dwarfism—in a global trial led by Melbourne&#039;s Murdoch Children&#039;s Research Institute.</description>
                    <link>https://medicalxpress.com/news/2019-06-drug-boosts-growth-youngsters-common.html</link>
                    <category></category>
                    <pubDate>Tue, 18 Jun 2019 09:11:22 EDT</pubDate>
                    <guid isPermaLink="false">news480067874</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2018/6-clinicaltria.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New dwarfism drug shows how innovation can be done well</title>
                    <description>Sara was born on a rainy Sunday, the first child to her adoring and overwhelmed parents. Her mother&#039;s pregnancy had been uneventful, and all their antenatal tests normal.</description>
                    <link>https://medicalxpress.com/news/2015-12-dwarfism-drug.html</link>
                    <category></category>
                    <pubDate>Thu, 03 Dec 2015 08:00:02 EST</pubDate>
                    <guid isPermaLink="false">news368350883</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2015/newdwarfismd.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
